Credit Suisse’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2
Closed -$2 3298
2022
Q4
$2 Sell
2
-29,078
-100% -$30.4K ﹤0.01% 3888
2022
Q3
$43K Buy
29,080
+214
+0.7% +$440 ﹤0.01% 3542
2022
Q2
$65K Sell
28,866
-1,057
-4% -$3.06K ﹤0.01% 3601
2022
Q1
$102K Buy
29,923
+2,030
+7% +$11K ﹤0.01% 3472
2021
Q4
$205K Buy
+27,893
New +$203K ﹤0.01% 4260

Other funds holding AVAH

Credit Suisse's AVAH Position: Q1 2023 in Review

Credit Suisse sold out of Aveanna Healthcare (AVAH) in Q1 2023, closing a stake of 2 shares — an estimated $2 sold.

Credit Suisse first reported a position in AVAH in Q4 2021 and held it in 5 quarters. The position peaked at $205K in Q4 2021. 68 funds tracked by Wall St. Rank hold AVAH as of Q1 2023.

  • Credit Suisse reported no remaining Aveanna Healthcare position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 2 Aveanna Healthcare shares in Q1 2023, an estimated $2.
  • Credit Suisse first reported a position in Aveanna Healthcare in Q4 2021 and held it in 5 quarters.
  • Credit Suisse's Aveanna Healthcare position peaked at $205K in Q4 2021.
  • 68 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.